Employee Benefits

The Inflation Reduction Act of 2022 introduces significant changes to Medicare Part D that could impact your company’s prescription drug coverage. From new out-of-pocket caps to insulin pricing, these updates may affect your plan’s status as “creditable” coverage.

The IRS has announced an increase in the ACA affordability threshold to 9.02% for 2025. This change may require employers to adjust health coverage contributions to remain compliant with ACA regulations and avoid penalties. Learn more about how these updates impact your responsibilities as an employer.

Employers are now required to submit annual RxDC reports detailing prescription drug and healthcare spending under the Consolidated Appropriations Act. This blog covers the key reporting requirements, deadlines, and steps to ensure compliance with federal regulations.

Employers sponsoring group health plans must comply with the Gag Clause Prohibition under the Consolidated Appropriations Act of 2021. This blog outlines key employer responsibilities, the steps for completing the required Gag Clause Prohibition Compliance Attestation, and tips for ensuring compliance to avoid penalties.

Employers offering prescription drug coverage must submit Medicare Part D Creditable Coverage Disclosures to CMS. Learn what it is, why it matters, and how to stay compliant.

As an employer offering prescription drug coverage, it’s essential to understand your obligations under Medicare Part D. This blog covers when to send Medicare Part D Notices, how to determine if your coverage is creditable, and best practices for staying compliant and protecting your employees from penalties.